Contact Us

Service Line:+1-315-239-3085

Address:FL-4, Building A5, International Enterprise Community, Tianjin, China

Email:info@kmdbioscience.com

Online Inquery

  •   
  •   
  •   
  • Refresh

Anti-Human CFD Recombinant Antibody

Product Information
Catalog Number YR1282
Product Name Anti-Human CFD Recombinant Antibody
Molecular Name Lampalizumab
Alias Anti-CFD Recombinant Antibody, Research Grade Lampalizumab
CAS Number 1278466-20-8
Target CFD[Homo sapiens]
Isotype Fab-G1 Kappa
Clonity Monoclonal
Host Mouse
Source CHO Cells
Size 1mg, 5mg
Concentration 1mg/ml
Purity >95% as determined by SDS-PAGE
Applications ELISA, IP, FCM, FuncS, Neut, IF, Stim
Buffer PBS, pH7.5
Background Lampalizumab (INN) is an antigen-binding fragment of a humanized monoclonal antibody that binds to complement factor D, it was developed as a potential treatment of geographic atrophy (atrophy of the retinal cells, retinal pigment epithelium, and choriocapillaris) secondary to age-related macular degeneration.
Storage It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note This product is for research use only.